The prevalence of diabetes is increasing, with an estimated 5% of Australians currently diagnosed with the chronic disease.1
Diabetes impacts quality of life, life expectancy and morbidity as a result of microvascular complications (retinopathy, nephropathy and neuropathy) and the increased risk of macrovascular complications (ischaemic vascular disease, stroke and peripheral vascular disease).2
Good glycaemic control reduces the development or progression of diabetes complications and can improve quality of life.2
About 60% of people with type 2 diabetes have cardiovascular disease and around 65% of all cardiovascular disease deaths in Australia occur in people with diabetes.3
Addressing lifestyle factors, blood pressure and blood lipids are just as essential, as they seem even more effective than glycaemic control in reducing the risk of cardiovascular complications.4
Reducing risk of cardiovascular events in people with type 2 diabetes requires concurrent management of lifestyle factors, blood pressure, lipids and blood glucose.1
Australian Institute of Health and Welfare. Diabetes. 2016. [Online] (accessed 31 May 2016).
Colagiuri S, Dickinson S, Girgis S, Colagiuri R. National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes. Diabetes Australia and the National Health and Medical Research Council, 2009. [Online] (accessed 26 July 2012).
Shaw J, Tanamas S. Diabetes: the silent pandemic and its impact on Australia. Baker IDI Heart and Diabetes Institute, 2012. [Online] (accessed 25 July 2012).